Urology · Evanston, IL
NPI
1578608949
Since 2007
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
6
Hospital affiliations
800 Austin St, Suite 569
Evanston, IL, 60202
Phone (847) 328-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$464K
7,986 services
Medicare patients, 2024
779
Average age 77
Drug cost, 2024
$475K
8,473 prescriptions
Company payments, 2025
$873
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter T Vaselopulos was code J1952 (leuprolide injectable, camcevi, 1 mg), 1,176 times for 25 patients. In total Peter T Vaselopulos billed 7,986 services in 56 codes, and Medicare paid $464K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,176 | 25 | $44.75 | $53K |
| 99214 Office E&M - Established | Office | 1,156 | 549 | $94.32 | $109K |
| 99232 Hospital E&M - Subsequent | Facility | 745 | 161 | $64.50 | $48K |
| 51798 Ultrasound - Nonspecific | Office | 703 | 371 | $8.11 | $5,702 |
| 99213 Office E&M - Established | Office | 566 | 316 | $64.80 | $37K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 541 | 339 | $13.10 | $7,085 |
| 99223 Hospital E&M - Initial | Facility | 198 | 166 | $141.43 | $28K |
| 52224 Cystourethroscopy | Office | 129 | 117 | $607.59 | $78K |
| 99204 Office E&M - New | Office | 87 | 87 | $102.96 | $8,957 |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 84 | 14 | $141.76 | $12K |
| 52000 Cystourethroscopy | Office | 73 | 60 | $177.96 | $13K |
| 51703 Other Organ Systems | Office | 62 | 35 | $123.80 | $7,676 |
| 99212 Office E&M - Established | Office | 61 | 20 | $41.50 | $2,532 |
| 51702 Other Organ Systems | Office | 45 | 33 | $46.36 | $2,086 |
| 52332 Cystourethroscopy | Facility | 44 | 35 | $112.07 | $4,931 |
By year: 2022 $418K for 13,584 services; 2023 $378K for 14,078 services; 2024 $464K for 7,986 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter T Vaselopulos prescribed most often to Medicare patients was Tamsulosin Hcl, with 1,808 prescriptions and refills. In total Peter T Vaselopulos wrote 8,473 Medicare prescriptions that cost $475K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 1,808 | 4,492 | 543 | $28K |
| Finasteride Generic | 1,694 | 4,265 | 496 | $20K |
| Cephalexin Generic | 1,204 | 1,330 | 411 | $6,398 |
| Bethanechol Chloride Generic | 664 | 1,267 | 182 | $26K |
| Levofloxacin Generic | 613 | 614 | 269 | $2,321 |
| Bicalutamide Generic | 176 | 465 | 60 | $5,395 |
| Nystatin Generic | 152 | 153 | 71 | $1,730 |
| Amoxicillin Generic | 140 | 142 | 72 | $523 |
| Potassium Citrate Er Potassium Citrate | 130 | 348 | 44 | $10K |
| Dutasteride Generic | 105 | 267 | 38 | $6,099 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 81 | 81 | 46 | $1,901 |
| Estradiol Generic | 80 | 267 | 48 | $4,628 |
| Clotrimazole Generic | 78 | 79 | 31 | $938 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 69 | 73 | 47 | $251 |
| Ketoconazole Generic | 68 | 75 | 32 | $901 |
Brand drugs: 229 claims; generic drugs: 8,228 claims; opioid claims: 24.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter T Vaselopulos $873 ($873 in general payments such as food, travel and fees) from 15 companies. The largest payer was Pfizer Inc. with $177.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 6 | $177 |
| Sumitomo Pharma America, Inc. 4506.T | 6 | $144 |
| Astellas Pharma US Inc 4503.T | 4 | $111 |
| Urogen Pharma, Inc. URGN | 5 | $98.66 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $67.8 |
| Tolmar, Inc. | 2 | $40.1 |
| Procept Biorobotics Corporation PRCT | 1 | $34.82 |
| Calliditas Therapeutics US Inc. | 1 | $34.12 |
| Madrigal Pharmaceuticals MDGL | 1 | $31.05 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $29.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.